Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 820 participants.
Also called NCT06987305
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 820 participants
- Registry
-
NCT06987305
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06987305. Randomized; quadruple masking; primary purpose treatment. Start 2025-10-21 (actual); primary completion 2027-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window
- Condition
- Stroke, Acute Ischemic
- Intervention (Drug)
- Intravenous rhTNK-tPA
- Intervention (Drug)
- Intravenous placebo
- Intervention (Procedure)
- Endovascular thrombectomy
- Lead sponsor
- Xinqiao Hospital of Chongqing
- Collaborator
- The First Affiliated Hospital of Nanchang University
- Collaborator
- China Shijiazhuang Pharmaceutical Company RECOMGEN PHARMACEUTICAL (GUANGZHOU) CO.,LTD
Record details
- Record id
cardio:ct-nct06987305- Content hash
7af972acd92721fe4360dcc24fc67aa548973023a4297ea716a9a34b2693971c